Addus HomeCare (NASDAQ:ADUS) Stock Price Expected to Rise, Stephens Analyst Says

Addus HomeCare (NASDAQ:ADUS) had its target price upped by Stephens from $143.00 to $145.00 in a report issued on Wednesday morning,Benzinga reports. They currently have an overweight rating on the stock.

A number of other research firms also recently commented on ADUS. KeyCorp assumed coverage on shares of Addus HomeCare in a research report on Friday, October 11th. They set an “overweight” rating and a $150.00 target price on the stock. Royal Bank of Canada cut their price objective on shares of Addus HomeCare from $141.00 to $136.00 and set an “outperform” rating on the stock in a report on Wednesday. Macquarie reissued an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a research note on Monday, November 4th. TD Cowen increased their target price on Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research report on Thursday, August 8th. Finally, Oppenheimer lifted their price target on Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a report on Monday, September 23rd. One investment analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $131.63.

Addus HomeCare Stock Down 1.2 %

Shares of NASDAQ:ADUS opened at $127.58 on Wednesday. The business’s 50 day moving average is $129.60 and its 200 day moving average is $121.40. The stock has a market cap of $2.31 billion, a P/E ratio of 29.19, a price-to-earnings-growth ratio of 2.30 and a beta of 1.04. Addus HomeCare has a 52-week low of $81.51 and a 52-week high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. The business had revenue of $289.80 million for the quarter, compared to the consensus estimate of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business’s revenue was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.03 EPS. On average, sell-side analysts anticipate that Addus HomeCare will post 4.57 EPS for the current fiscal year.

Insider Transactions at Addus HomeCare

In related news, EVP Michael D. Wattenbarger sold 21,917 shares of the company’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the transaction, the executive vice president now directly owns 7,215 shares of the company’s stock, valued at $961,687.35. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the business’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the sale, the executive vice president now owns 7,215 shares of the company’s stock, valued at approximately $961,687.35. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Esteban Lopez sold 500 shares of the company’s stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total transaction of $63,750.00. Following the transaction, the director now owns 3,366 shares in the company, valued at $429,165. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 22,917 shares of company stock valued at $3,050,082 in the last quarter. 4.60% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Addus HomeCare

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ADUS. UMB Bank n.a. raised its position in Addus HomeCare by 64.2% during the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after buying an additional 88 shares during the last quarter. Quest Partners LLC acquired a new stake in shares of Addus HomeCare in the second quarter worth $31,000. Farther Finance Advisors LLC raised its holdings in shares of Addus HomeCare by 9,150.0% during the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock worth $49,000 after purchasing an additional 366 shares during the last quarter. Innealta Capital LLC acquired a new position in Addus HomeCare during the second quarter valued at $44,000. Finally, EntryPoint Capital LLC acquired a new position in Addus HomeCare during the first quarter valued at $44,000. Hedge funds and other institutional investors own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.